UNLABELLED: Primary biliary cirrhosis (PBC) is generally a slowly progressive disease that may lead to cirrhosis and liver failure. However, patients with PBC often suffer from a variety of symptoms long before the development of cirrhosis that include issues of daily living that have an impact on their work environment and their individual quality of life. We therefore examined multiple parameters by taking advantage of the database of our cohort of 1032 patients with PBC and 1041 matched controls. The data were obtained from patients from 23 tertiary referral centers throughout the United States and from rigorously matched controls by age, sex, ethnicity, and random-digit dialing. The data showed that patients with PBC were more likely than controls to have significant articular symptoms, a reduced ability to perform household chores, and the need for help with routine activities. Patients with PBC rated their overall activity similar or superior to that of controls; however, more of them reported limitations in their ability to carry out activities at work or at home and difficulties in everyday activities. PBC cases also more frequently reported limitations in participating in certain sports or exercises and pursuing various hobbies; however, they did not report significant limitations in social activities. In a multivariable analysis, household income, a diagnosis of systemic lupus erythematosus, limitations in work activities, a reduction in work secondary to disability, and church attendance were independently increased in PBC cases with respect to controls. CONCLUSION: Our data indicate that the quality of life of patients with PBC in the United States is generally well preserved. Nevertheless, patients with PBC suffer significantly more than controls from a variety of symptoms that are beyond the immediate impact of liver failure and affect their lifestyle, personal relationships, and work activities.
UNLABELLED: Primary biliary cirrhosis (PBC) is generally a slowly progressive disease that may lead to cirrhosis and liver failure. However, patients with PBC often suffer from a variety of symptoms long before the development of cirrhosis that include issues of daily living that have an impact on their work environment and their individual quality of life. We therefore examined multiple parameters by taking advantage of the database of our cohort of 1032 patients with PBC and 1041 matched controls. The data were obtained from patients from 23 tertiary referral centers throughout the United States and from rigorously matched controls by age, sex, ethnicity, and random-digit dialing. The data showed that patients with PBC were more likely than controls to have significant articular symptoms, a reduced ability to perform household chores, and the need for help with routine activities. Patients with PBC rated their overall activity similar or superior to that of controls; however, more of them reported limitations in their ability to carry out activities at work or at home and difficulties in everyday activities. PBC cases also more frequently reported limitations in participating in certain sports or exercises and pursuing various hobbies; however, they did not report significant limitations in social activities. In a multivariable analysis, household income, a diagnosis of systemic lupus erythematosus, limitations in work activities, a reduction in work secondary to disability, and church attendance were independently increased in PBC cases with respect to controls. CONCLUSION: Our data indicate that the quality of life of patients with PBC in the United States is generally well preserved. Nevertheless, patients with PBC suffer significantly more than controls from a variety of symptoms that are beyond the immediate impact of liver failure and affect their lifestyle, personal relationships, and work activities.
Authors: William W Eaton; Noel R Rose; Amanda Kalaydjian; Marianne G Pedersen; Preben Bo Mortensen Journal: J Autoimmun Date: 2007-06-19 Impact factor: 7.094
Authors: Carmen M Stanca; Nancy Bach; Cynthia Krause; Nidhi Tandon; Maria A Freni; Julio A Gutierrez; Carol Bodian; Jose Lopez; Paul D Berk; Henry C Bodenheimer; Andrea D Branch; Joseph A Odin Journal: Am J Gastroenterol Date: 2005-05 Impact factor: 10.864
Authors: Carlo Selmi; Susan R Ross; Aftab A Ansari; Pietro Invernizzi; Mauro Podda; Ross L Coppel; M Eric Gershwin Journal: Gastroenterology Date: 2004-08 Impact factor: 22.682
Authors: Carlo Selmi; Marlyn J Mayo; Nancy Bach; Hiromi Ishibashi; Pietro Invernizzi; Robert G Gish; Stuart C Gordon; Harlan I Wright; Bruce Zweiban; Mauro Podda; M Eric Gershwin Journal: Gastroenterology Date: 2004-08 Impact factor: 22.682
Authors: Jennifer Y Lee; Christopher J Danford; Hirsh D Trivedi; Elliot B Tapper; Vilas R Patwardhan; Alan Bonder Journal: Dig Dis Sci Date: 2019-01-10 Impact factor: 3.199
Authors: Andrea Crosignani; Pier-Maria Battezzati; Pietro Invernizzi; Carlo Selmi; Elena Prina; Mauro Podda Journal: World J Gastroenterol Date: 2008-06-07 Impact factor: 5.742
Authors: Lorenzo Montali; Andrea Gragnano; Massimo Miglioretti; Alessandra Frigerio; Luca Vecchio; Alessio Gerussi; Laura Cristoferi; Vincenzo Ronca; Daphne D'Amato; Sarah Elizabeth O'Donnell; Clara Mancuso; Martina Lucà; Minami Yagi; Anna Reig; Laura Jopson; Sesé Pilar; Dave Jones; Albert Pares; George Mells; Atsushi Tanaka; Marco Carbone; Pietro Invernizzi Journal: J Transl Autoimmun Date: 2021-01-06
Authors: Katarzyna Kotarska; Ewa Wunsch; Agnieszka Kempińska-Podhorodecka; Joanna Raszeja-Wyszomirska; Dimitrios P Bogdanos; Maciej Wójcicki; Piotr Milkiewicz Journal: J Immunol Res Date: 2014-03-04 Impact factor: 4.818